vs
Side-by-side financial comparison of Arhaus, Inc. (ARHS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $364.8M, roughly 1.7× Arhaus, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 4.1%, a 30.3% gap on every dollar of revenue. On growth, Arhaus, Inc. posted the faster year-over-year revenue change (5.1% vs 4.8%). Over the past eight quarters, Arhaus, Inc.'s revenue compounded faster (11.2% CAGR vs 4.6%).
Arhaus, Inc.ARHSEarnings & Financial Report
Arhaus, Inc. is an upscale American home furnishings company headquartered in Boston Heights, Ohio. Founded in 1986 with a focus on sustainability and artisanship in product quality, Arhaus provides a diversified assortment of specialty goods and services addressing omnichannel direct-to-consumer and business-to-business residential and commercial operations.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
ARHS vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $364.8M | $622.0M |
| Net Profit | $15.1M | $214.2M |
| Gross Margin | 38.1% | — |
| Operating Margin | 5.6% | 62.4% |
| Net Margin | 4.1% | 34.4% |
| Revenue YoY | 5.1% | 4.8% |
| Net Profit YoY | -29.1% | 2.9% |
| EPS (diluted) | $0.11 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $364.8M | $622.0M | ||
| Q3 25 | $344.6M | $609.3M | ||
| Q2 25 | $358.4M | $578.7M | ||
| Q1 25 | $311.4M | $568.2M | ||
| Q4 24 | $347.0M | $593.6M | ||
| Q3 24 | $319.1M | $564.7M | ||
| Q2 24 | $309.8M | $537.3M | ||
| Q1 24 | $295.2M | $568.0M |
| Q4 25 | $15.1M | $214.2M | ||
| Q3 25 | $12.2M | $288.2M | ||
| Q2 25 | $35.1M | $30.2M | ||
| Q1 25 | $4.9M | $238.3M | ||
| Q4 24 | $21.3M | $208.2M | ||
| Q3 24 | $9.9M | $544.0M | ||
| Q2 24 | $22.2M | $102.0M | ||
| Q1 24 | $15.1M | $4.8M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 41.4% | — | ||
| Q1 25 | 37.1% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 38.6% | — | ||
| Q2 24 | 40.1% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 5.6% | 62.4% | ||
| Q3 25 | 4.8% | 70.1% | ||
| Q2 25 | 13.0% | 36.3% | ||
| Q1 25 | 1.7% | 94.0% | ||
| Q4 24 | 8.2% | 60.9% | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 9.5% | 50.2% | ||
| Q1 24 | 6.2% | -13.0% |
| Q4 25 | 4.1% | 34.4% | ||
| Q3 25 | 3.5% | 47.3% | ||
| Q2 25 | 9.8% | 5.2% | ||
| Q1 25 | 1.6% | 41.9% | ||
| Q4 24 | 6.1% | 35.1% | ||
| Q3 24 | 3.1% | 96.3% | ||
| Q2 24 | 7.2% | 19.0% | ||
| Q1 24 | 5.1% | 0.8% |
| Q4 25 | $0.11 | $0.49 | ||
| Q3 25 | $0.09 | $0.67 | ||
| Q2 25 | $0.25 | $0.07 | ||
| Q1 25 | $0.03 | $0.55 | ||
| Q4 24 | $0.15 | $0.46 | ||
| Q3 24 | $0.07 | $1.21 | ||
| Q2 24 | $0.16 | $0.23 | ||
| Q1 24 | $0.11 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $253.4M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $418.2M | $9.7B |
| Total Assets | $1.4B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $253.4M | $618.7M | ||
| Q3 25 | $262.2M | $938.9M | ||
| Q2 25 | $234.8M | $631.9M | ||
| Q1 25 | $214.4M | $1.1B | ||
| Q4 24 | $197.5M | $929.0M | ||
| Q3 24 | $177.7M | $950.1M | ||
| Q2 24 | $174.2M | $1.8B | ||
| Q1 24 | $233.2M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $418.2M | $9.7B | ||
| Q3 25 | $400.4M | $9.6B | ||
| Q2 25 | $385.6M | $9.5B | ||
| Q1 25 | $348.8M | $9.8B | ||
| Q4 24 | $343.7M | $10.3B | ||
| Q3 24 | $320.6M | $10.3B | ||
| Q2 24 | $309.3M | $9.8B | ||
| Q1 24 | $285.6M | $9.9B |
| Q4 25 | $1.4B | $19.6B | ||
| Q3 25 | $1.4B | $19.3B | ||
| Q2 25 | $1.3B | $18.3B | ||
| Q1 25 | $1.3B | $17.6B | ||
| Q4 24 | $1.2B | $18.2B | ||
| Q3 24 | $1.2B | $18.0B | ||
| Q2 24 | $1.2B | $17.7B | ||
| Q1 24 | $1.2B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.3M | $827.1M |
| Free Cash FlowOCF − Capex | $-8.8M | — |
| FCF MarginFCF / Revenue | -2.4% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 0.62× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $59.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.3M | $827.1M | ||
| Q3 25 | $46.1M | $702.6M | ||
| Q2 25 | $34.9M | $364.0M | ||
| Q1 25 | $46.5M | $596.1M | ||
| Q4 24 | $31.7M | $742.5M | ||
| Q3 24 | $31.1M | $703.6M | ||
| Q2 24 | $47.5M | $658.2M | ||
| Q1 24 | $36.8M | $664.6M |
| Q4 25 | $-8.8M | — | ||
| Q3 25 | $28.0M | — | ||
| Q2 25 | $20.9M | — | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $13.0M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $11.3M | — | ||
| Q1 24 | $10.9M | — |
| Q4 25 | -2.4% | — | ||
| Q3 25 | 8.1% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 8.8% | — |
| Q4 25 | 0.62× | 3.86× | ||
| Q3 25 | 3.77× | 2.44× | ||
| Q2 25 | 1.00× | 12.06× | ||
| Q1 25 | 9.53× | 2.50× | ||
| Q4 24 | 1.49× | 3.57× | ||
| Q3 24 | 3.14× | 1.29× | ||
| Q2 24 | 2.14× | 6.45× | ||
| Q1 24 | 2.44× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARHS
| Sales Channel Retail | $305.7M | 84% |
| Sales Channel E Commerce | $59.2M | 16% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
